Jundishapur Journal of Microbiology

Published by: Kowsar

In-Vitro Evaluation of Antifungal Activity of Terbinafine and Terbinafine Nano-Drug Against Clinical Isolates of Dermatophytes

Nazila Motedayen 1 , Seyed Jamal Hashemi 2 , * , Sassan Rezaei 2 and Mansour Bayat 1
Authors Information
1 Department of Microbiology, Science and Research Branch, Islamic Azad University, Tehran, IR Iran
2 Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sceinces, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: May 2018, 11 (5); e62351
  • Published Online: April 17, 2018
  • Article Type: Research Article
  • Received: September 30, 2017
  • Revised: March 4, 2018
  • Accepted: March 15, 2018
  • DOI: 10.5812/jjm.62351

To Cite: Motedayen N, Hashemi S J, Rezaei S, Bayat M. In-Vitro Evaluation of Antifungal Activity of Terbinafine and Terbinafine Nano-Drug Against Clinical Isolates of Dermatophytes, Jundishapur J Microbiol. 2018 ; 11(5):e62351. doi: 10.5812/jjm.62351.

Copyright © 2018, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusions
  • 1. Abd Elmegeed ASM, Ouf S, Moussa TA, Eltahlawi S. Dermatophytes and other associated fungi in patients attending to some hospitals in Egypt. Brazil J Microbiol. 2015;46(3):799-805. doi: 10.1590/S1517-838246320140615. [PubMed: 26413063].
  • 2. Cox RA. Immunology of the fungal diseases. CRC Press; 1989.
  • 3. Zamani S, Sadeghi G, Yazdinia F, Moosa H, Pazooki A, Ghafarinia Z, et al. Epidemiological trends of dermatophytosis in Tehran, Iran: A five-year retrospective study. J Mycol Med. 2016;26(4):351-8. doi: 10.1016/j.mycmed.2016.06.007. [PubMed: 27520535].
  • 4. Faure-Cognet O, Fricker-Hidalgo H, Pelloux H, Leccia MT. Superficial Fungal Infections in a French Teaching Hospital in Grenoble Area: Retrospective Study on 5470 Samples from 2001 to 2011. Mycopathologia. 2016;181(1-2):59-66. doi: 10.1007/s11046-015-9953-7. [PubMed: 26452757].
  • 5. Budak A, Bogusz B, Tokarczyk M, Trojanowska D. Dermatophytes isolated from superficial fungal infections in Krakow, Poland, between 1995 and 2010. Mycoses. 2013;56(4):422-8. doi: 10.1111/myc.12043. [PubMed: 23346893].
  • 6. Vena GA, Chieco P, Posa F, Garofalo A, Bosco A, Cassano N. Epidemiology of dermatophytoses: retrospective analysis from 2005 to 2010 and comparison with previous data from 1975. New Microbiol. 2012;35(2):207-13. [PubMed: 22707134].
  • 7. Roberts DT, Evans EG. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol. 1998;138(1):189-90. [PubMed: 9536247].
  • 8. Zhu M, Li L, Wang J, Zhang C, Kang K, Zhang Q. Tinea capitis in Southeastern China: a 16-year survey. Mycopathologia. 2010;169(4):235-9. doi: 10.1007/s11046-009-9260-2. [PubMed: 19936963].
  • 9. Fallahi AA, Rezaei-Matehkolaei A, Rezaei S. Epidemiological status of dermatophytosis in Guilan, north of Iran. Curr Med Mycol. 2017;3(1):20. doi: 10.29252/cmm.3.1.20. [PubMed: 29302626].
  • 10. Revankar SG, Graybill JR, Patterson TF. Antifungal Agents and Antifungal Susceptibility Testing. Topley Wilson's Microbiol Microb Infect. doi: 10.1002/9780470688618.taw0134.
  • 11. Mukherjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MA. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother. 2003;47(1):82-6. [PubMed: 12499173].
  • 12. Mendes AI, Silva AC, Catita JA, Cerqueira F, Gabriel C, Lopes CM. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity. Colloids Surf B Biointerfaces. 2013;111:755-63. doi: 10.1016/j.colsurfb.2013.05.041. [PubMed: 23954816].
  • 13. Gupta M, Vyas SP. Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids. 2012;165(4):454-61. doi: 10.1016/j.chemphyslip.2012.01.006. [PubMed: 22309657].
  • 14. Azanza Perea JR, Barberan J. Anfotericina B forma liposómica: un perfil farmacocinético exclusivo. Una historia inacabada. Revista Espanola de Quimioterapia. 2012;25(1).
  • 15. Mozafari MR. Liposomes. Nanoliposomes: preparation and analysis. Springer; 2010. p. 29-50.
  • 16. John HR. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, approved standard. M38-A2. Clin Lab Stand Inst. 2008;16:1-35.
  • 17. White TJ, Thomas Bruns SJ, Lee WT, Taylor JL. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics." PCR protocols: a guide to methods and applications. 1990. Available from: http://msafungi.org/wp-content/uploads/Inoculum/64(1).pdf.
  • 18. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55(3):329-47. [PubMed: 12628320].
  • 19. Tang X, Zhu H, Sun L, Hou W, Cai S, Zhang R, et al. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo. Int J Nanomedicine. 2014;9:5403-13. doi: 10.2147/IJN.S71623. [PubMed: 25473279].
  • 20. Osborne CS, Leitner I, Hofbauer B, Fielding CA, Favre B, Ryder NS. Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine. Antimicrob Agents Chemother. 2006;50(6):2234-6. doi: 10.1128/AAC.01600-05. [PubMed: 16723593].
  • 21. Osborne CS, Leitner I, Favre B, Ryder NS. Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine. Antimicrob Agents Chemother. 2005;49(7):2840-4. doi: 10.1128/AAC.49.7.2840-2844.2005. [PubMed: 15980358].
  • 22. Paiao FG, Segato F, Cursino-Santos JR, Peres NT, Martinez-Rossi NM. Analysis of Trichophyton rubrum gene expression in response to cytotoxic drugs. FEMS Microbiol Lett. 2007;271(2):180-6. doi: 10.1111/j.1574-6968.2007.00710.x. [PubMed: 17425668].
  • 23. Sharma S, Sharma U. Synthesis, characterization and determination of encapsulation efficiency of chitosan nanoparticles for terbinafine. Indo Am J Pharm Res. 2013;3(12):1564-7.
  • 24. Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits. AAPS PharmSciTech. 2013;14(2):782-93. doi: 10.1208/s12249-013-9964-y. [PubMed: 23615773].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments